May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Expression of PAR-1, PAR-3 and PAR-4 in Human Choroidal Neovascular Membranes
Author Affiliations & Notes
  • F. J. Adamakos
    Pathology, Henry C. Witelson Ocular Pathology Laboratory, Pierrefonds, Quebec, Canada
  • S. Maloney
    Pathology, Henry C. Witelson Ocular Pathology Laboratory, Pierrefonds, Quebec, Canada
  • E. Antecka
    Pathology, Henry C. Witelson Ocular Pathology Laboratory, Pierrefonds, Quebec, Canada
  • B. F. Fernandes
    Pathology, Henry C. Witelson Ocular Pathology Laboratory, Pierrefonds, Quebec, Canada
  • E. Castiglione
    Pathology, Henry C. Witelson Ocular Pathology Laboratory, Pierrefonds, Quebec, Canada
  • M. N. Burnier, Jr.
    Pathology, Henry C. Witelson Ocular Pathology Laboratory, Pierrefonds, Quebec, Canada
  • Footnotes
    Commercial Relationships  F.J. Adamakos, None; S. Maloney, None; E. Antecka, None; B.F. Fernandes, None; E. Castiglione, None; M.N. Burnier, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3409. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. J. Adamakos, S. Maloney, E. Antecka, B. F. Fernandes, E. Castiglione, M. N. Burnier, Jr.; Expression of PAR-1, PAR-3 and PAR-4 in Human Choroidal Neovascular Membranes. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3409. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Protease-activated receptors (PARs) have been shown to promote disease progression in cancer by playing critical roles in angiogenesis. Accordingly, PARs may promote abnormal non-neoplastic neovascularization such as in patients with Age-related Macular Degeneration (AMD). The aim of this study was to investigate expression of PARs in choroidal neovascular membranes (CNV) excised from patients with neovascular AMD.

Methods: : Formalin-fixed, paraffin-embedded sections of CNV membranes surgically excised from 8 patients with AMD were immunostained for PAR-1, PAR-3 and PAR-4 expression, using the Ventana BenchMark fully automated machine. Staining was evaluated by a trained ocular pathologist and classified as either negative or positive in each of the following cell types: retinal pigment epithelial cells (RPE), vascular endothelial cells and fibroblasts. Two control eyes from patients with no history of AMD were obtained from the eye bank and were also stained.

Results: : Five of 8 (63%) CNV membranes stained positive for PAR-1 in RPE cells and 6 of 8 (75%) stained positive in vascular endothelial cells. Only 2 of 8 (25%) stained positive for PAR-1 in fibroblasts. All CNV membranes stained positive for PAR-3 in RPE cells, while 7 of 8 (89%) stained positive in vascular endothelial cells and 5 of 8 (63%) stained positive in fibroblasts. None of the CNV membranes stained for PAR-4 in RPE cells, while 2 of 8 (25%) stained positive for PAR-4 in vascular endothelial cells and 5 of 8 (63%) stained positive in fibroblasts. Control eyes stained positive in the RPE and the choroid for all three receptors.

Conclusions: : We observed different expression of each PAR in AMD-related CNVs. Most notably, PAR-4 expression was absent in RPE cells in all membranes yet positive in the RPE of control eyes. It is possible that the loss of PAR-4 expression in RPE cells plays an important role in the development of CNV in AMD patients. Further investigation is warranted to elucidate the significance of this finding.

Keywords: age-related macular degeneration • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×